Fetal and neonatal germ cell tumors

Seminars in Fetal and Neonatal Medicine

Volumn 17, Issue 4, 2012, Pages 222-230

  Frazier, A Lindsay ^a   Weldon, Christopher ^a   Amatruda, James ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Germ cell tumor; Germinoma; Molecular genetics; Neonatal; Teratoma; Yolk sac tumor

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CISPLATIN; ETOPOSIDE; METHOTREXATE;

CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CARDIOVASCULAR DISEASE; CELL MIGRATION; CHORIOCARCINOMA; CHROMOSOME 12P; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECTODERM; ENDODERM; FETAL TUMOR; GENOME IMPRINTING; GERM CELL; GERM CELL TUMOR; HISTOLOGY; HUMAN; KIDNEY DISEASE; MOLECULAR GENETICS; MULTIPLE CYCLE TREATMENT; NEWBORN DISEASE; NIDATION; OTOTOXICITY; PATHOGENESIS; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SURGICAL TECHNIQUE; TERATOMA; TREATMENT OUTCOME; YOLK SAC TUMOR;

FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS;

EID: 84862200188     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2012.05.004     Document Type: Review

References (58)

1. Ries L.A.G., Smith M.A., Gurney J.G., et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 1999, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649, Bethesda, MD.
2. Isaacs H. Congenital and neonatal malignant tumors. A 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol 1987, 9:121-129.
3. Isaacs H. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg 2004, 39:1003-1013.
4. Norris H.J., Zirkin H.J., Benson W.L. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976, 37:2359-2372.
5. Heifetz S.A., Cushing B., Giller R., et al. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. Am J Surg Pathol 1998, 22:1115-1124.
6. Cushing B., Giller R., Ablin A., et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the Pediatric Oncology Group and the Children's Cancer Group. Am J Obstet Gynecol 1999, 181:353-358.
7. Marina N.M., Cushing B., Giller R., et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol 1999, 17:2137-2143.
8. Isaacs H. Germ cell tumors. Potter's pathology of the fetus, infant and child 2007, 1690-1709. Mosby, St Louis. E.K.R. Gilbert-Barness, L.L. Oligny, J.R. Siebert (Eds.).
9. Nogales F., Talerman A., Kubich-Huch R.A., Tavassoli F.A., Devouassoux-Shisheboran M. Germ cell tumours. World Health Organization classification of tumours: tumours of the breast and female genital organs 2003, 163-179. IARC Press, Lyon. F.A. Tavassoli, P. Devilee (Eds.).
10. Woodward P.J., Heidenreich A., Looijenga L.H.J., et al. Germ cell tumours. World Health Organization classification of tumours: tumours of the urinary system and male genital organs 2004, 221-250. IARC Press, Lyon. J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn (Eds.).
11. Blohm M.E., Göbel U. Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review. Eur J Pediatr 2004, 163:1-6.
12. Szavay P.O., Wermes C., Fuchs J., et al. Effective treatment of infantile choriocarcinoma in the liver with chemotherapy and surgical resection: a case report. J Pediatr Surg 2000, 35:1134-1135.
13. Johnson E.J., Crofton P.M., Wallace W.H. Infantile choriocarcinoma treated with chemotherapy alone. Med Pediatr Oncol 2003, 41:550-557.
14. Heath J.A., Tiedemann K. Successful management of neonatal choriocarcinoma. Med Pediatr Oncol 2001, 36:497-499.
15. Cools M., Drop S.L., Wolffenbuttel K.P., Oosterhuis J.W., Looijenga L.H. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006, 27:468-484.
16. Rajpert-De Meyts E., Hanstein R., Jorgensen N., et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod 2004, 19:1338-1344.
17. Chen Y.H., Chang C.H., Chen K.C., et al. Malignant transformation of a well-organized sacrococcygeal fetiform teratoma in a newborn male. J Formos Med Assoc 2007, 106:400-402.
18. Huddart S.N., Mann J.R., Robinson K., et al. Sacrococcygeal teratomas: the UK Children's Cancer Study Group's experience. I. Neonatal. Pediatr Surg Int 2003, 19:47-51.
19. Gabra H.O., Jesudason E.C., McDowell H.P., et al. Sacrococcygeal teratoma -a 25-year experience in a UK regional center. J Pediatr Surg 2006, 41:1513-1516.
20. Makin E.C., Hyett J., Ade-Ajayi N., et al. Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004). J Pediatr Surg 2006, 41:388-393.
21. Swamy R., Embleton N., Hale J. Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes. Prenat Diagn 2008, 28:1048-1051.
22. Jelin E., Jelin A.C., Lee H. Sacrococcygeal teratoma with spinal canal invasion prenatally diagnosed. J Pediatr Surg 2009, 44:E9-11.
23. Looijenga L.H., Stoop H., de Leeuw H.P., et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003, 63:2244-2250.
24. Spencer R. Parasitic conjoined twins: external, internal (fetuses in fetu and teratomas), and detached (acardiacs). Clin Anat 2001, 14:428-444.
25. Altman R.P., Randolph J.G., Lilly J.R. Sacrococcygeal teratoma: American Academy of Pediatrics Surgical Section Survey - 1973. J Pediatr Surg 1974, 9:389-398.
26. Gobel U., Calaminus G., Engert J., et al. Teratomas in infancy and childhood. Med Pediatr Oncol 1998, 31:8-15.
27. Rescorla F., Billmire D., Stolar C., et al. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882). J Pediatr Surg 2001, 36:12-17.
28. Gobel U., Schneider D.T., Calaminus G., et al. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. J Clin Oncol 2001, 19:1943-1950.
29. De Backer A., Madern G.C., Hakvoort-Cammel F.G., et al. Study of the factors associated with recurrence in children with sacrococcygeal teratoma. J Pediatr Surg 2006, 41:173-181. discussion 173-81.
30. Gobel U., Calaminus G., Schneider D.T., et al. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol. Klin Padiatr 2006, 218:309-314.
31. Cushing B., Giller R., Cullen J.W., et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 2004, 22:2691-2700.
32. Wu J.T., Book L., Sudar K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res 1981, 15:50-52.
33. Blohm M.E., Vesterling-Horner D., Calaminus G., Gobel U. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 1998, 15:135-142.
34. Mazumdar M., Bajorin D.F., Bacik J., Higgins G., Motzer R.J., Bosl G.J. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 2001, 19:2534-2541.
35. Rogers P.C., Olson T.A., Cullen J.W., et al. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study - Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 2004, 22:3563-3569.
36. Mann J.R., Raafat F., Robinson K., et al. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 2000, 18:3809-3818.
37. Escobar M.A., Rossman J.E., Caty M.G. Fetus-in-fetu: report of a case and a review of the literature. J Pediatr Surg 2008, 43:943-946.
38. Hopkins K.L., Dickson P.K., Ball T.I., et al. Fetus-in-fetu with malignant recurrence. J Pediatr Surg 1997, 32:1476-1479.
39. Malone P.S., Spitz L., Kiely E.M., et al. The functional sequelae of sacrococcygeal teratoma. J Pediatr Surg 1990, 25:679-680.
40. Schmidt B., et al. Sacrococcygeal teratoma: clinical course and prognosis with a special view to long-term functional results. Pediatr Surg Int 1999, 15:573-576.
41. Ozkan K.U., Bauer S.B., Khoshbin S., Borer J.G. Neurogenic bladder dysfunction after sacrococcygeal teratoma resection. J Urol 2006, 175:292-296.
42. Kerner B., Flaum E., Mathews H., et al. Cervical teratoma: prenatal diagnosis and long-term follow-up. Prenat Diagn 1998, 18:51-59.
43. Liechty K.W., Crombleholme T.M., Flake A.W., et al. Intrapartum airway management for giant fetal neck masses: the EXIT (ex utero intrapartum treatment) procedure. Am J Obstet Gynecol 1997, 170:870-874.
44. Hedrick M.H., Ferro M.M., Filly R.A., et al. Congenital high airway obstruction syndrome (CHAOS): a potential for perinatal intervention. J Pediatr Surg 1994, 29:271-274.
45. Bouchard S., Johnson M.P., Flake A.W., et al. The EXIT procedure: experience and outcome in 31 cases. J Pediatr Surg 2002, 37:418-426.
46. Riedlinger W.F.J., Lack E.E., Robson C., Rahbar R., Nose V. Primary thyroid teratomas in children: a report of 11 cases with a proposal of criteria for their diagnosis. Am J Surg Pathol 2005, 29:700-706.
47. Martino F., Avila L.F., Encinas J.L., et al. Teratomas of the neck and mediastinum in children. Pediatr Surg Int 2006, 22:627-634.
48. Azizkhan R.G., Haase G.M., Applebaum H., et al. Diagnosis, management, and outcome of cervicofacial teratomas in neonates: a Children's Cancer Group study. J Pediatr Surg 1995, 30:312-316.
49. Billmire D., Vinocur C., Rescorla F., et al. Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study. J Pediatr Surg 2003, 38:315-318.
50. Billmire D.F., Grosfeld J.L. Teratomas in childhood: analysis of 142 cases. J Pediatr Surg 1986, 21:548-551.
51. Hart J., Mazrani W., Jones N., et al. Upper abdominal teratomas in infants: radiological findings and importance of the vascular anatomy. Pediatr Radiol 2008, 3:750-755.
52. De Backer A., Madern G.C., Hazebroek F.W.J. Retroperitoneal germ cell tumors: a clinical study of 12 patients. J Pediatr Surg 2005, 40:1475-1481.
53. Eyssartier E., Harper L., Michel J.L., et al. Rapidly growing mature retroperitoneal teratomas. J Pediatr Hematol Oncol 2009, 31:705-706.
54. Merchant A.M., Hedrick H.L., Johnson M.P., et al. Management of fetal mediastinal teratoma. J Pediatr Surg 2005, 40:228-231.
55. Billmire D., Vinocur C., Rescorla F., et al. Malignant mediastinal germ cell tumors: an intergroup study. J Pediatr Surg 2001, 36:18-24.
56. Frazier A.L., Amatruda J. Pediatric germ cell tumors. Oncology of infancy and childhood 2009, 911-962. Saunders/Elsevier, Philadelphia. 1st ed. S.H. Orkin, D.E. Fisher, T.A. Look (Eds.).
57. Travis L.B., Beard C., Allan J.M., et al. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst 2010, 102:1114-1130.
58. Hale J. 'Carboplatin (CBP) is equivalent to cisplatin (CP) within prognostic groups in paediatric extracranial malignant germ cell tumours (MGCTs).' Oral presentation at the 2012 meeting of the American Society of Clinical Oncology, Chicago, Ilinois, USA, June 2012.